The global Point of Care & Rapid Diagnostics market size was valued at US$ million in 2023. With growing demand in downstream market, the Point of Care & Rapid Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Point of Care & Rapid Diagnostics market. Point of Care & Rapid Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Point of Care & Rapid Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Point of Care & Rapid Diagnostics market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Point of Care & Rapid Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Point of Care & Rapid Diagnostics market. It may include historical data, market segmentation by Type (e.g., Rapid Test, Molecular Diagnostics), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Point of Care & Rapid Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Point of Care & Rapid Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Point of Care & Rapid Diagnostics industry. This include advancements in Point of Care & Rapid Diagnostics technology, Point of Care & Rapid Diagnostics new entrants, Point of Care & Rapid Diagnostics new investment, and other innovations that are shaping the future of Point of Care & Rapid Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Point of Care & Rapid Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Point of Care & Rapid Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Point of Care & Rapid Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Point of Care & Rapid Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Point of Care & Rapid Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Point of Care & Rapid Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Point of Care & Rapid Diagnostics market.
Market Segmentation:
Point of Care & Rapid Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Rapid Test
Molecular Diagnostics
Segmentation by application
Hospital
Home Care
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson and Johnson
Thermo Fisher Scientific
Bio-Techne
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
BD
Sysmex
Cardinal Health
Quidel
GE Healthcare
EKF Diagnostics
bioM茅rieux SA
Accubiotech
PTS Diagnostics
Chembio Diagnostics
Trinity Biotech
Sekisui Diagnostics
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Point of Care & Rapid Diagnostics Market Size 2019-2030
2.1.2 Point of Care & Rapid Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Point of Care & Rapid Diagnostics Segment by Type
2.2.1 Rapid Test
2.2.2 Molecular Diagnostics
2.3 Point of Care & Rapid Diagnostics Market Size by Type
2.3.1 Point of Care & Rapid Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Point of Care & Rapid Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Point of Care & Rapid Diagnostics Segment by Application
2.4.1 Hospital
2.4.2 Home Care
2.5 Point of Care & Rapid Diagnostics Market Size by Application
2.5.1 Point of Care & Rapid Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Point of Care & Rapid Diagnostics Market Size Market Share by Application (2019-2024)
3 Point of Care & Rapid Diagnostics Market Size by Player
3.1 Point of Care & Rapid Diagnostics Market Size Market Share by Players
3.1.1 Global Point of Care & Rapid Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Point of Care & Rapid Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Point of Care & Rapid Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Point of Care & Rapid Diagnostics by Regions
4.1 Point of Care & Rapid Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Point of Care & Rapid Diagnostics Market Size Growth (2019-2024)
4.3 APAC Point of Care & Rapid Diagnostics Market Size Growth (2019-2024)
4.4 Europe Point of Care & Rapid Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Point of Care & Rapid Diagnostics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Point of Care & Rapid Diagnostics Market Size by Country (2019-2024)
5.2 Americas Point of Care & Rapid Diagnostics Market Size by Type (2019-2024)
5.3 Americas Point of Care & Rapid Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point of Care & Rapid Diagnostics Market Size by Region (2019-2024)
6.2 APAC Point of Care & Rapid Diagnostics Market Size by Type (2019-2024)
6.3 APAC Point of Care & Rapid Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Point of Care & Rapid Diagnostics by Country (2019-2024)
7.2 Europe Point of Care & Rapid Diagnostics Market Size by Type (2019-2024)
7.3 Europe Point of Care & Rapid Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Point of Care & Rapid Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Point of Care & Rapid Diagnostics Market Forecast
10.1 Global Point of Care & Rapid Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Point of Care & Rapid Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Point of Care & Rapid Diagnostics Forecast
10.1.3 APAC Point of Care & Rapid Diagnostics Forecast
10.1.4 Europe Point of Care & Rapid Diagnostics Forecast
10.1.5 Middle East & Africa Point of Care & Rapid Diagnostics Forecast
10.2 Americas Point of Care & Rapid Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Point of Care & Rapid Diagnostics Market Forecast
10.2.2 Canada Point of Care & Rapid Diagnostics Market Forecast
10.2.3 Mexico Point of Care & Rapid Diagnostics Market Forecast
10.2.4 Brazil Point of Care & Rapid Diagnostics Market Forecast
10.3 APAC Point of Care & Rapid Diagnostics Forecast by Region (2025-2030)
10.3.1 China Point of Care & Rapid Diagnostics Market Forecast
10.3.2 Japan Point of Care & Rapid Diagnostics Market Forecast
10.3.3 Korea Point of Care & Rapid Diagnostics Market Forecast
10.3.4 Southeast Asia Point of Care & Rapid Diagnostics Market Forecast
10.3.5 India Point of Care & Rapid Diagnostics Market Forecast
10.3.6 Australia Point of Care & Rapid Diagnostics Market Forecast
10.4 Europe Point of Care & Rapid Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Point of Care & Rapid Diagnostics Market Forecast
10.4.2 France Point of Care & Rapid Diagnostics Market Forecast
10.4.3 UK Point of Care & Rapid Diagnostics Market Forecast
10.4.4 Italy Point of Care & Rapid Diagnostics Market Forecast
10.4.5 Russia Point of Care & Rapid Diagnostics Market Forecast
10.5 Middle East & Africa Point of Care & Rapid Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Point of Care & Rapid Diagnostics Market Forecast
10.5.2 South Africa Point of Care & Rapid Diagnostics Market Forecast
10.5.3 Israel Point of Care & Rapid Diagnostics Market Forecast
10.5.4 Turkey Point of Care & Rapid Diagnostics Market Forecast
10.5.5 GCC Countries Point of Care & Rapid Diagnostics Market Forecast
10.6 Global Point of Care & Rapid Diagnostics Forecast by Type (2025-2030)
10.7 Global Point of Care & Rapid Diagnostics Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Information
11.1.2 Johnson and Johnson Point of Care & Rapid Diagnostics Product Offered
11.1.3 Johnson and Johnson Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Johnson and Johnson Main Business Overview
11.1.5 Johnson and Johnson Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Point of Care & Rapid Diagnostics Product Offered
11.2.3 Thermo Fisher Scientific Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Bio-Techne
11.3.1 Bio-Techne Company Information
11.3.2 Bio-Techne Point of Care & Rapid Diagnostics Product Offered
11.3.3 Bio-Techne Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bio-Techne Main Business Overview
11.3.5 Bio-Techne Latest Developments
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Information
11.4.2 Roche Diagnostics Point of Care & Rapid Diagnostics Product Offered
11.4.3 Roche Diagnostics Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Roche Diagnostics Main Business Overview
11.4.5 Roche Diagnostics Latest Developments
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Information
11.5.2 Siemens Healthineers Point of Care & Rapid Diagnostics Product Offered
11.5.3 Siemens Healthineers Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Siemens Healthineers Main Business Overview
11.5.5 Siemens Healthineers Latest Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Information
11.6.2 Abbott Laboratories Point of Care & Rapid Diagnostics Product Offered
11.6.3 Abbott Laboratories Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abbott Laboratories Main Business Overview
11.6.5 Abbott Laboratories Latest Developments
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Information
11.7.2 Danaher Corporation Point of Care & Rapid Diagnostics Product Offered
11.7.3 Danaher Corporation Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Danaher Corporation Main Business Overview
11.7.5 Danaher Corporation Latest Developments
11.8 BD
11.8.1 BD Company Information
11.8.2 BD Point of Care & Rapid Diagnostics Product Offered
11.8.3 BD Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BD Main Business Overview
11.8.5 BD Latest Developments
11.9 Sysmex
11.9.1 Sysmex Company Information
11.9.2 Sysmex Point of Care & Rapid Diagnostics Product Offered
11.9.3 Sysmex Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sysmex Main Business Overview
11.9.5 Sysmex Latest Developments
11.10 Cardinal Health
11.10.1 Cardinal Health Company Information
11.10.2 Cardinal Health Point of Care & Rapid Diagnostics Product Offered
11.10.3 Cardinal Health Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Cardinal Health Main Business Overview
11.10.5 Cardinal Health Latest Developments
11.11 Quidel
11.11.1 Quidel Company Information
11.11.2 Quidel Point of Care & Rapid Diagnostics Product Offered
11.11.3 Quidel Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Quidel Main Business Overview
11.11.5 Quidel Latest Developments
11.12 GE Healthcare
11.12.1 GE Healthcare Company Information
11.12.2 GE Healthcare Point of Care & Rapid Diagnostics Product Offered
11.12.3 GE Healthcare Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 GE Healthcare Main Business Overview
11.12.5 GE Healthcare Latest Developments
11.13 EKF Diagnostics
11.13.1 EKF Diagnostics Company Information
11.13.2 EKF Diagnostics Point of Care & Rapid Diagnostics Product Offered
11.13.3 EKF Diagnostics Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 EKF Diagnostics Main Business Overview
11.13.5 EKF Diagnostics Latest Developments
11.14 bioM茅rieux SA
11.14.1 bioM茅rieux SA Company Information
11.14.2 bioM茅rieux SA Point of Care & Rapid Diagnostics Product Offered
11.14.3 bioM茅rieux SA Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 bioM茅rieux SA Main Business Overview
11.14.5 bioM茅rieux SA Latest Developments
11.15 Accubiotech
11.15.1 Accubiotech Company Information
11.15.2 Accubiotech Point of Care & Rapid Diagnostics Product Offered
11.15.3 Accubiotech Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Accubiotech Main Business Overview
11.15.5 Accubiotech Latest Developments
11.16 PTS Diagnostics
11.16.1 PTS Diagnostics Company Information
11.16.2 PTS Diagnostics Point of Care & Rapid Diagnostics Product Offered
11.16.3 PTS Diagnostics Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 PTS Diagnostics Main Business Overview
11.16.5 PTS Diagnostics Latest Developments
11.17 Chembio Diagnostics
11.17.1 Chembio Diagnostics Company Information
11.17.2 Chembio Diagnostics Point of Care & Rapid Diagnostics Product Offered
11.17.3 Chembio Diagnostics Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Chembio Diagnostics Main Business Overview
11.17.5 Chembio Diagnostics Latest Developments
11.18 Trinity Biotech
11.18.1 Trinity Biotech Company Information
11.18.2 Trinity Biotech Point of Care & Rapid Diagnostics Product Offered
11.18.3 Trinity Biotech Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Trinity Biotech Main Business Overview
11.18.5 Trinity Biotech Latest Developments
11.19 Sekisui Diagnostics
11.19.1 Sekisui Diagnostics Company Information
11.19.2 Sekisui Diagnostics Point of Care & Rapid Diagnostics Product Offered
11.19.3 Sekisui Diagnostics Point of Care & Rapid Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Sekisui Diagnostics Main Business Overview
11.19.5 Sekisui Diagnostics Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
